Grants

Through our IIS Grants Program, Teleflex is committed to supporting the advancement of scientific knowledge, improved patient outcomes and the quality of healthcare through original, diverse, investigator-initiated proposals. We invite you to submit your proposal for support. Please consider submitting your request in English. Submission in languages other than English will require translation and may result in an extended period of time for review and consideration.

Eligibility:

Grant-eligible submissions may be pre-clinical, post-mortem, in vitro, and/or human clinical in the areas of vascular access, anesthesia, emergency medicine, cardiac care, interventional access, urology, and surgical.

Note of disclosure:

As of January 2012, U.S. Federal law requires that companies collect information relating to payments and transfers of value and submit this information to the government for publication on the CMS Open Payments website. Teleflex complies with this law.

Requirements / Responsibilities:

Investigators must:

• be qualified by training and experience to lead the proposed research
• not be excluded, debarred, suspended, or otherwise ineligible to participate in health-care programs
• not be an employee of Teleflex
• be the originator of the research idea and author the concept/protocol

The Investigator is responsible for conducting the study in accordance with the protocol (developed by the Investigator), applicable institution policies, generally accepted standards of Good Clinical Practice (GCP)/Good Laboratory Practice (GLP), and all applicable laws and regulations governing the performance of the study.

The IIS Grant Request will be reviewed to assess the viability of the grant. For initial review the following information will be required:

• Research Objective
• Type of support requested
• Completed IIS Grant Request Form

If Teleflex determines that the IIS Grant Request requires more information to make a determination of viability, Clinical and Medical Affairs will contact the requestor for additional information.

After initial review the IIS grant panel will make final assessment and determination of support or declination.

Review of the IIS Grant Request depends on the completion of the IIS Grant Request Form. Missed information may delay the review process.

IIS Grant Request Form

Approval / Acceptance:

All proposals will be reviewed based on scientific merit and available funding. Once a proposal is endorsed, Teleflex will request review of the final approved protocol to ensure it accurately reflects the endorsed proposal. This final approved protocol will be a part of the agreement between the research institution and Teleflex. Unfortunately, not all proposals will be endorsed. Teleflex will notify you of our decision as soon as possible after the review of the submission.

Summary of IIS Process:

	Sponsor-Investigator	Teleflex
Grant Request and Initial Review	Research Objective Type of support requested Requestor/Investigator Name, Affiliation Contact info	Initial reviews for probability of approval Confirm Investigator is not on the disqualification/debarment list Request additional information, as needed Notification of initial grant viability
Grant Panel Review	Additional requested documentation which may include: Investigator's CV Study Protocol/Protocol Abstract Budget IRB/EC/IACUC requirements (if applicable) Investigator's License Number Publication plan	Request additional documentation (as applicable) Review submission Communicate final decision to support or decline the submission Inform approved applicants of next steps
Grant	Submit final required documentation and information requested Final Study Protocol IRB/EC/IACUC requirements (if applicable)	Review all submitted final documents Negotiate, finalize, and execute agreement
	Activation	Issue initial support per agreement
Study Conduct	Research Update: Provide monthly progress updates (required)	Monitor monthly updates
	Data reporting: Submit final study report; a manuscript may be used as the final deliverable, per study agreement	Review submitted final study report.
	Final reconciliation	Determine if any excess support should be returned to Teleflex and notify Investigator

If you are unable to submit your request via the online form, please contact us via the email listed below:

Email: Rdg.Clinical.Research@teleflex.com